Larisse Longo

9PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsMetabolic medicinePredictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 04, 2025
Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non-alcoholic Fatty Liver Disease.

Jéssica Tonin Ferrari, Gabriel Tayguara Silveira Guerreiro, Larisse Longo

|Jul 13, 2024
Redefining the Role of Ornithine Aspartate and Vitamin E in Metabolic-Dysfunction-Associated Steatotic Liver Disease through Its Biochemical Properties.

Larisse Longo, Rafael Aguiar Marschner, Laura Bainy Rodrigues de Freitas

|Mar 21, 2024
COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS.

Cássio Marques Perlin, Larisse Longo, Rutiane Ullmann Thoen

|Mar 18, 2024
Extracellular Vesicles and Their Correlation with Inflammatory Factors in an Experimental Model of Steatotic Liver Disease Associated with Metabolic Dysfunction.

Melina Belén Keingeski, Larisse Longo, Vitória Brum da Silva Nunes

|Apr 13, 2023
Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Rafael Aguiar Marschner, Ana Cristina Roginski, Rafael Teixeira Ribeiro

Pageof 2